Home Tags Biosimilars

Tag: Biosimilars

News

Mallinckrodt & Silence Therapeutics to develop RNAi therapeutics

Mallinckrodt & Silence Therapeutics to develop RNAi therapeutics

Mallinckrodt will work with Silence Therapeutics under a new collaboration to develop and commercialise novel RNA2 interference (RNAi) therapeutics for complement-mediated diseases. The agreement will...
New CRISPR license framework to encourage innovation

New CRISPR license framework to encourage innovation

MilliporeSigma and the Broad Institute of MIT and Harvard will together offer non-exclusive licenses to CRISPR IP under their respective control for use in...
AUM licenses first-in-class targeted cancer therapy

AUM licenses first-in-class targeted cancer therapy

Singapore’s AUM Biosciences (AUM) is licensing Inflection Biosciences first-in-class PIM/PI3K/mTOR inhibitors. Under the agreement, AUM will develop, manufacture and commercialise the inhibitors. Known as the IBL-300...